Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma

In 2001, it was postulated that tumour-derived exosomes could be a potent source of tumour-associated antigens (TAA). Since then, much knowledge is gained on their role in tumorigenesis but only very recently tumour-derived exosomes were used in dendritic cell (DC)-based immunotherapy. For this, DCs...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of extracellular vesicles 2013-01, Vol.2 (1), p.1-n/a
Hauptverfasser:	Mahaweni, Niken M., Kaijen-Lambers, Margaretha E.H., Dekkers, Jacqueline, Aerts, Joachim G.J.V., Hegmans, Joost P.J.J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animal models Antigen (tumor-associated) Antigen presentation Bone marrow Brain tumors Cancer Cell culture Centrifuges Cytotoxicity dendritic cell(s) Dendritic cells Drug dosages Electron microscopy Exosomes Freeze-thawing Full text Immunogenicity Immunotherapy Lethal dose Melanoma Mesothelioma Metastases Methods Microscopy Proteins Short Communication Sonication Studies Tumorigenesis Tumors tumour antigens Ultracentrifugation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!